Scientists from the RIKEN Center for Emergent Matter Science and colleagues have developed a new way to fabricate ...
The project is part of Build The Earth, a global initiative launched by YouTube creator PippenFTS to recreate the entire ...
Minecraft Immersive Structures is a popular mod that adds loads of new structures to the game. Though the game has its fair share of structures in all three dimensions, many players felt that it could ...
Compass stock has just received a modest bump in its fair value estimate, rising from about $10.22 per share to approximately $10.67 as analysts recalibrate their models around the pending Anywhere ...
Two U.S. Senators are urging antitrust officials to take a close look at the potential merger between Compass and Anywhere Real Estate. Senators Elizabeth Warren and Ron Wyden warned in a letter ...
SAN FRANCISCO, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
Shareholders were extremely pleased by the biotech's latest news from the lab. This concerned its pipeline weight-loss drug aleniglipron. Structure, which concentrates on metabolic diseases with a ...
Dec 8 (Reuters) - Structure Therapeutics (GPCR.O), opens new tab said on Monday its obesity pill showed weight loss of up to 11.3% after 36 weeks of treatment in a mid-stage study, driving the company ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The South San Francisco biotech ...
Compass Minerals International, Inc. (NYSE: CMP) will release earnings results for the fourth quarter after the closing bell on Monday, Dec. 8. Analysts expect the Overland Park, Kansas-based company ...
At 13 years old, Robert Reffkin went to his mother with a plan to become a DJ. She said no, but Reffkin kept pushing. She eventually agreed to help him buy equipment and drive him to gigs. “You don’t ...
CEO Kabir Nath highlighted "the potential 9- to 12-month acceleration of our launch plans that we announced today" as a key update, citing the completion of enrollment for the COMP006 Phase III trial ...